Click to open
Skip to content
ICNE
8th International Conference on Neurology and Epidemiology
  • Home
  • Program
  • Oral Presentations 2022
  • Video on Demand 2021
  • Eposters
  • Privacy Policy
  • Home
  • Program
  • Oral Presentations 2022
  • Video on Demand 2021
  • Eposters
  • Privacy Policy
Click Here

Go to Top

Join a meeting

Oral Presentations
Session NumberPresenterSessionPresentation titleTimeAccess
OP-1Amir SharifOral PresentationsHydrogen sulfide-based therapeutics for neurological conditions09:29 minView Oral Presentation
OP-2Jendé ZijlmansOral PresentationsThe role of cognitive and brain reserve in late-life depression09:41 minView Oral Presentation
OP-3Sabah RehmanOral PresentationsSex Differences in Delayed Cerebral Ischemia and Hydrocephalus after Aneurysmal Subarachnoid Haemorrhage (aSAH) - A Systematic Review and Meta-Analysis09:38 minView Oral Presentation
OP-4Iago PerissinottiOral PresentationsStroke etiologies in patients with COVID-1919:18 minView Oral Presentation
OP-5Thuy NguyenOral PresentationsFacilitators to more timely treatment following aneurysmal subarachnoid hemorrhage in Southest Australia: results from na embedded mixed-methods study10:05 minnot available
OP-6Gita SorayaOral PresentationsSignificant Association between the COMT, MAO-B, and DRD2 Polymorphisms with susceptibility to Motor Levodopa-induced Complications (MLIC) in15:38 minView Oral Presentation
OP-7Abolfazl AvanOral PresentationsAge-, sex-, and risk-specific burden of neurological diseases in the North Africa and Middle East from 1990 to 2019: A systematic analysis of data from the Global Burden of Disease Study 201907:58 minView Oral Presentation
OP-8Rita KrishnamurthiOral PresentationsIncidence of Stroke during the SARS-COV-2 Pandemic in New Zealand; Findings from ARCOS V, 202011:28 minView Oral Presentation
Videos on Demand
Session NumberPresenterSessionPresentation titleTimeAccess
TS-1B. NorrvingTeaching Session: Meet the EditorsMeet the Immediate Past Editor of European Stroke Journal18:21 minView Presentation
TS-2V. FeiginTeaching Session: Meet the Editors Meet the Editor of Neuroepidemiology20:11 minView Presentation
P1-1E. WestenbergPlenary Session #1: Neurological Disorders and COVID-19 Global COVID-19 Neuro Research Coalition08:05 minView Presentation
P1-2M. GiroudPlenary Session #1: Neurological Disorders and COVID-19 Telemedicine in Neurology since the COVID-19 pandemic12:08 minView Presentation
P1-3D. GandhiPlenary Session #1: Neurological Disorders and COVID-19 Neurological rehabilitation during the COVID-19 pandemic: What changes and what have we learnt27:44 minView Presentation
P1-4T. WijeratnePlenary Session #1: Neurological Disorders and COVID-19 Post Covid-19 Neurological Syndrome - Current Status and Future Perspective15:15 minView Presentation
P1-5D. GandhiPlenary Session #1: Neurological Disorders and COVID-19 Telerehabilitation for Neurological care- how real is the impact across the world- HIC versus LMIC perspectives29:25 minView Presentation
P1-6V. FeiginPlenary Session #1: Neurological Disorders and COVID-19 Primary stroke and cardiovascular disease prevention strategy needs overhaul10:03 minView Presentation
P2-1M. ChunPlenary Session #2: Application of Risk Prediction (Scores) in Neurology What the COVID-19 crisis is telling humanity11:04 minView Presentation
P3-1G. BiesselsPlenary Session #3: Neuroepidemiology of Cognition Lesion location helps to better understand cognitive impact of cerebrovascular disease: the Mata VCI Map consortium12:37 minView Presentation
P3-2A. BrodtmannPlenary Session #3: Neuroepidemiology of Cognition Targeting exercise to prevent vascular cognitive impairment: the Post-Ischaemic Stroke Cardiovascular Exercise Study11:20 minView Presentation
P3-3S. PendleburyPlenary Session #3: Neuroepidemiology of Cognition Epidemiology and novel risk factors for dementia after stroke14:43 minView Presentation
P3-4C. ChenPlenary Session #3: Neuroepidemiology of Cognition Preventing Vascular Cognitive Impairment with multiple lifestyle interventions15:09 minView Presentation
P4-1E. HarshfieldPlenary Session #4: Genetics and Application of Mendelian Randomisation in NeurologyMetabolic associations with stroke, dementia, and imaging markers of cerebral small vessel disease: a comprehensive metabolomics study06:54 minView Presentation
P4-2R. AkinyemiPlenary Session #4: Genetics and Application of Mendelian Randomisation in NeurologyGenetics of stroke in Africans 17:21 minView Presentation
P5-1C. KetzoianPlenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases Multiple Sclerosis Incidence in Uruguay: A Population-based Study14:28 minView Presentation
P5-2J. CorrealePlenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases Barriers to access and utilization of multiple sclerosis care services in Latin American patients20:53 minView Presentation
P5-3C. KetzoianPlenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases Poverty and neurological disorders in middle-low income countries15:39 minView Presentation
P5-4F. GraciaPlenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases Prevalence and incidence surveys of MS in Latin America and the Caribbean18:11 minView Presentation
P5-5J. CorrealePlenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases Environmental factors involved in the development of MS in Latin America27:36 minView Presentation
SP-1D. WiebersSpecial session: Brain Health, One Health and COVID-19Brain Health, One Health, COVID-19 and Our Collective Future16:55 minView Presentation
SP-2M. BraininSpecial session: Brain Health, One Health and COVID-19'Brain Health': vision or study endpoint? 24:35 minView Presentation
SP-3A. WinklerSpecial session: Brain Health, One Health and COVID-19Advantages of a One Health Approach For Communicable and Noncommunicable Diseases27:34 minView Presentation
SP-4A. QuainSpecial session: Brain Health, One Health and COVID-19One Welfare, the Role of Health Professionals and Climate Change21:13 minView Presentation
SP-5T. WyattSpecial session: Brain Health, One Health and COVID-19Harm, Earth Juris Prudence and Human/Nonhuman Relationships20:12 minView Presentation
SP-6K. LeeSpecial session: Brain Health, One Health and COVID-19Rethinking Global Governance to Address Zoonotic Disease Risk26:37 minView Presentation
P6-1M. OlaiyaPlenary Session #6: Statistical Techniques to Improve the Use of Observational DataPropensity score techniques13:12 minView Presentation
P6-2C. RiberholtPlenary Session #6: Statistical Techniques to Improve the Use of Observational DataStatistical considerations for reducing the risk of type I or II errors in systematic reviews and meta-analysis14:32 minView Presentation
P6-3M. KilkennyPlenary Session #6: Statistical Techniques to Improve the Use of Observational DataTarget trial approach14:27 minView Presentation
P6-4D. CadilhacPlenary Session #6: Statistical Techniques to Improve the Use of Observational DataPatient reported outcomes for guiding clinical practice, comparing service performance, and clinical data interpretation15:07 minView Presentation
P7-1J. PandianPlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICArtificial Intelligence in stroke epidemiology13:21 minView Presentation
P7-2W. WangPlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICEpidemiology and community control of epilepsy in rural areas of China15:27 minView Presentation
P7-3J. ChopraPlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICNeuropsychological rehabilitation in low resource settings - Challenges and outcomes12:18 minView Presentation
P7-4J. PandianPlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICMethodology for documentation of stroke deaths in LMICs: challenges and way forward12:48 minView Presentation
P7-5D. SunPlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICEpidemiology of brain injury11:55 minView Presentation
P7-6J. PandianPlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICHow to integrate stroke implementation research in health care system of developing countries12:47 minView Presentation
P7-7S. GePlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICEpidemiology of stroke and TIA14:52 minView Presentation
P7-8J. ChopraPlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICCognitive and psychological rehabilitation in psychogenic non-epileptic seizures versus generalized epilepsy11:42 minView Presentation
P7-9A. WinklerPlenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMICChallenges and Opportunities of neurological research in sub-Saharan Africa12:57 minView Presentation
S1-1M. Alt MurphyScientific Session 1: Stroke and DementiaUpper limb sensorimotor assessment after stroke – recommendations and implementation17:14 minView Presentation
S1-2P. SachdevScientific Session 1: Stroke and DementiaCognition, function and prevalent dementia in Centenarians and Near-Centenarians: an individual participant data (IPD) meta-analysis of 18 studies16:11 minView Presentation
S1-3D. BennettScientific Session 1: Stroke and DementiaMTHFR and risk of stroke, ischemic heart disease and major non-vascular diseases: a Mendelian randomization study of Chinese adults23:19 minView Presentation
S1-4M. Alt MurphyScientific Session 1: Stroke and DementiaVirtual Reality in stroke rehabilitation 19:53 minView Presentation
S1-5D. BennettScientific Session 1: Stroke and DementiaCausal associations of blood lipids with risk of ischaemic stroke and intracerebral haemorrhage20:48 minView Presentation
S1-6R. AkinyemiScientific Session 1: Stroke and DementiaThe burden of stroke in Africa17:47 minView Presentation
S1-7D. GabrielScientific Session 1: Stroke and DementiaLong-term prognosis of primary intracerebral hemorrhage in XXI century: hospital cohorts compared to population-based cohorts10:36 minView Presentation
S2-1S. MartinsScientific Session 2: Using Research to Change Stroke PoliciesHow to use registries and epidemiological data to change policies?15:18 minView Presentation
S2-2Y. BéjotScientific Session 2: Using Research to Change Stroke PoliciesClinical profile gap between stroke patients included in therapeutic trials and those in real-life practice: an important issue to deal with14:04 minView Presentation
S2-3O. Pontes NetoScientific Session 2: Using Research to Change Stroke PoliciesHow to translate clinical trials in national policies?15:23 minView Presentation
S2-4S. MartinsScientific Session 2: Using Research to Change Stroke PoliciesThe gaps and solutions for primary prevention across the globe - to show the gaps and what the countries are doing to improve14:15 minView Presentation
S3-1M. MorrisScientific Session 3: International Networks to Advance Neurological Science & PracticeThe Power of Dance for Parkinson’s: Developing Global Networks14:52 minView Presentation
S3-2C. OrellanaScientific Session 3: International Networks to Advance Neurological Science & PracticeThe Collaboration of Aphasia Trialists; standardizing assessments to measure aphasia rehabilitation09:32 minView Presentation
S3-3R. FoxScientific Session 3: International Networks to Advance Neurological Science & PracticeGlobal Collaboration: Lessons from Multiple Sclerosis11:21 minView Presentation
S3-4G. VerheydenScientific Session 3: International Networks to Advance Neurological Science & PracticeThe International Stroke Recovery & Rehabilitation Alliance13:16 minView Presentation
P8-1Y. Béjot Plenary Session #8: Cognitive Impairment and DementiaStroke in patients with cognitive impairment13:57 minView Presentation
P8-2R. AkinyemiPlenary Session #8: Cognitive Impairment and DementiaEpidemiology, profile and determinant of post - stroke vascular cognitive impairment 18:52 minView Presentation
P8-3O. GodefroyPlenary Session #8: Cognitive Impairment and DementiaDiagnosis and management of post-stroke cognitive impairment in clinical practice16:33 minView Presentation
P8-4G. LogroscinoPlenary Session #8: Cognitive Impairment and DementiaFrontiers: FTD Incidence in Europe10:53 minView Presentation
P8-5S. DebettePlenary Session #8: Cognitive Impairment and DementiaCerebral small vessel disease in patients with cognitive decline17:50 minView Presentation
P8-6G. LogroscinoPlenary Session #8: Cognitive Impairment and DementiaCognitive Impairment and Hearing Loss16:40 minView Presentation
P8-7D. DingPlenary Session #8: Cognitive Impairment and DementiaOlfactory dysfunction and risk of cognitive decline among older adults20:05 minView Presentation
P9-1T. WijeratnePlenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and HeadachesHeadache in ED11:30 minView Presentation
P9-2T. O´BrienPlenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and HeadachesSudden onset death in epilepsy (SUDEP): Can it be prevented?17:19 minView Presentation
P9-3G. LogroscinoPlenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and HeadachesPsychotic and Behavioral Symptoms in neurodegenerative diseases14:42 minView Presentation
P9-4J. WanigasinghePlenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and HeadachesEpidemiology of epilepsy in the South East Asian region14:32 minView Presentation
P9-5T. WijeratnePlenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and HeadachesThe Success story of World Brain Day16:30 minView Presentation
P9-6J. HinmanPlenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and HeadachesAntecedent autoimmune conditions and amyotrophic lateral sclerosis12:48 minView Presentation
P9-7E. ZimmerPlenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and HeadachesNew perspectives in research for Alzheimer Disease 15:38 minView Presentation
P9-8L. NelsonPlenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and HeadachesDiabetes, Diabetes Medications and the Risk of Developing ALS14:42 minView Presentation
Videos on Demand
Session NumberPresenterSessionPresentation titleTimeAccess
T1-1D. DingTeaching Session #1: Basics of clinical neuroepidemiology (observational studies) Aims, design and pitfalls of cross-sectional studies: Application of cross-sectional design in large-sampled multicentered population-based surveys18:55 minView Session
T1-2X. LengTeaching Session #1: Basics of clinical neuroepidemiology (observational studies) Writing a scientific paper and reporting an observational study21:22 minView Session
T1-3Y. PanTeaching Session #1: Basics of clinical neuroepidemiology (observational studies) Aims, design and pitfalls of cohort studies12:38 minView Session
T2-1D. BennettTeaching Session #2: Basics of clinical epidemiology Basics of biostatistics24:17 minView Session
T2-2G. LogroscinoTeaching Session #2: Basics of clinical epidemiology Type, design and pitfalls of rcts and meta-analysis22:45 minView Session
T2-3D. BennettTeaching Session #2: Basics of clinical epidemiology Guidelines for reporting neuroepidemiological studies18:27 minView Session
T3-1D. BennettTeaching Session #3: Basics of clinical epidemiology (continued) Strengths and limitations of statistical analyses28:20 minView Session
T3-2G. LogroscinoTeaching Session #3: Basics of clinical epidemiology (continued) Studies and methods for descriptive epidemiology of rare neurodegenerative diseases in population studies18:59 minView Session
ME-1B. NorrvingMeet the Editors Publishing your manuscript: My best advice28:10 minView Session
ME-2V. FeiginMeet the Editors Neuroepidemiology: Hints for publication29:16 minView Session
P1-WV. FeiginGlobal impact of COVID Welcome Message from the Chair 03:21 minView Session
P1-1D. WiebersGlobal impact of COVID What the COVID-19 crisis is telling humanity (keynote lecture)15:18 minView Session
P1-2E. BeghiGlobal impact of COVID Impact of COVID-19 on neurological disorders08:03 minView Session
P1-3L. LiuGlobal impact of COVID Impact of COVID-19 on stroke care in China11:00 minView Session
P2-1M. OwolabiStroke prevention and policy implications The Lancet Neurology Commission on stroke: Evidence-based pragmatic solution to reduce the global burden of stroke (keynote lecture)11:07 minView Session
P2-2G. MensahStroke prevention and policy implications Data science advances in the global prevention and treatment of stroke11:29 minView Session
P2-3B. NorrvingStroke prevention and policy implications Using stroke statistics for policy purposes - challenges and opportunities10:16 minView Session
P2-4V. FeiginStroke prevention and policy implications Practical solution for motivational mass stroke prevention10:25 minView Session
P2-5A. TowfighiStroke prevention and policy implications From evidence to practice: What are we doing wrong?10:21 minView Session
P3-1R. KrishnamurthiUpdates on and breaking news in clinical trials on stroke and dementia Health & Wellness Coaching for primary stroke prevention: PREVENTS trial (keynote lecture)12:58 minView Session
P3-2Y. TeuschlUpdates on and breaking news in clinical trials on stroke and dementia The effects of the polypill in primary stroke prevention09:47 minView Session
P3-3S. DavisUpdates on and breaking news in clinical trials on stroke and dementia Endovascular thrombectomy - the challenges10:33 minView Session
P3-4M. BraininUpdates on and breaking news in clinical trials on stroke and dementia Cognitive post-stroke disturbance (keynote lecture)16:00 minView Session
P3-5J. PandianUpdates on and breaking news in clinical trials on stroke and dementia Community health workers for stroke prevention. What is the evidence?13:38 minView Session
P3-6P. SachdevUpdates on and breaking news in clinical trials on stroke and dementia New consortia for studying dementia (COSMIC, STROKOG, and ICC) (keynote lecture)14:17 minView Session
P3-7A. IkramUpdates on and breaking news in clinical trials on stroke and dementia Updates on dementia incidence, prevalence and risk factors in Europe14:40 minView Session
P3-8R. Azarpazhooh Updates on and breaking news in clinical trials on stroke and dementia Why dementia incidence rates are declining09:33 minView Session
P4-1T. VosNeuroepidemiology and Biomarkers of movement disorders Global Burden of Neurological disorders11:08 minView Session
P4-2M. DichgansNeuroepidemiology and Biomarkers of movement disorders Updates on genetics in stroke risk10:13 minView Session
P4-3C. KetzoianNeuroepidemiology and Biomarkers of movement disorders Neuroepidemiology in Latin America09:41 minView Session
P4-4Y. BéjotNeuroepidemiology and Biomarkers of movement disorders Impact of the ageing population on the contemporary profile of stroke patients: lessons from population-based registries08:33 minView Session
P4-5B. SabayanNeuroepidemiology and Biomarkers of movement disorders Heart-brain axis and brain health11:14 minView Session
P4-6B. MillerNeuroepidemiology and Biomarkers of movement disorders Frontotemporal dementia18:48 minView Session
P4-7H. ZetterbergNeuroepidemiology and Biomarkers of movement disorders Update on fluid biomarkers for Alzheimer's disease15:06 minView Session
P5-1W. CarrollNeurological care and rehabilitation (1) Barriers to neurological care: Addressing the needs (keynote lecture)13:23 minView Session
P5-2J. BernhardtNeurological care and rehabilitation (1) Updates on post-stroke rehabilitation09:51 minView Session
P5-3M. Alt MurphyNeurological care and rehabilitation (1) Predictors of stroke recovery07:47 minView Session
P5-4A. BonkhoffNeurological care and rehabilitation (1) Brain connectivity and recovery08:33 minView Session
P5-5A. ThiftNeurological care and rehabilitation (1) "They’ve got a bit better and they’re good enough to go back…” perspectives on stroke rehabilitation for aboriginal survivors07:36 minView Session
P6-1W. WangEpidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disordersEpidemiology of stroke in China (keynote lecture)12:47 minView Session
P6-2P. SachdevEpidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disordersThe epidemiology of neurocognitive disorders from around the globe: findings from the COSMIC collaboration12:47 minView Session
P6-3G. DeuschlEpidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disordersChanges in the epidemiology of neurological disorders in Europe 11:14 minView Session
P6-4T. WijeratneEpidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disordersIncreased global burden of headaches25:14 minView Session
P6-5M. HittleEpidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disordersNeurocoach - A Virtual Therapist for Post-Stroke Recovery09:50 minView Session
P6-6M. GiroudEpidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disordersPsychosocial factors and stroke07:50 minView Session
P6-7D. CadilhacEpidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders10 years of the Australian Stroke Clinical Registry: How the data have been used to inform policy and practice?10:59 minView Session
S1-1A. GabetScientific Session #1Impact of the COVID-19 pandemic and a national lockdown on hospitalization for stroke and related 30-day mortality in France: a nationwide observational study14:32 minView Session
S1-2A. GabetScientific Session #1Characteristics, management and in-hospital mortality of patients hospitalized for stroke with a concomitant diagnostic of COVID-19 in France09:54 minView Session
S1-3N. De JongScientific Session #1White matter network structure as a substrate of cognitive brain reserve in cerebral small vessel disease: the maastricht study09:53 minView Session
S1-4M. VergonjeanneScientific Session #1Epidemiology of epilepsy in low- and middle-income countries: experience of a standardized questionnaire over the past two decades08:29 minView Session
S1-5L. DuffnerScientific Session #1Can engagement in socially and cognitively stimulating leisure activities compensate for other dementia risk factors? A prospective cohort study08:47 minView Session
S2-1O. FilipetsScientific Session #2Incidence of stroke in the urban area of western ukraine: temporal trends and features of statistical accounting11:03 minView Session
S2-2R. S. RagavanScientific Session #2Impact of varying look-back periods on estimating the number of person-based first-ever occurrences of strokes using linked hospitalisation data08:13 minView Session
S2-3K. RobinsonScientific Session #2Long-term risk of stroke in 123, 696 people with existing cardiac disease: a study using data linkage10:17 minView Session
S2-4Z. OrmanScientific Session #2Quality of life after stroke in a cluster randomized trial. Findings from standfirm07:23 minView Session
S3-1T. Ullberg, K. MånssonScientific Session #3Structured multimodal follow-up after stroke: implementation aspects of a new paradigm11:11 minView Session
S3-2M. KilkennyScientific Session #3Australian Stroke Data Linkage Program: Using data to improve outcomes08:55 minView Session
S3-3T. GreenScientific Session #3Disorders of Consciousness (doc): Implications for nursing along the continuum26:06 minView Session
S3-4N. OkubadejoScientific Session #3Utilizing disease registries to scale up neurology research in Africa: Experience from the Nigeria Parkinson Disease Registry09:17 minView Session
S3-5M. OlaiyaScientific Session #3Disparities by diabetes status in the quality of care and long-term outcomes following acute stroke or transient ischaemic attack07:14 minView Session
S3-6S. GallScientific Session #3Evaluating the effect of personalised knowledge to reduce the risk of stroke (PERKS-International) – study design protocol07:35 minView Session
S4-1A. EliakunduScientific Session #4Paramedic identification of stroke and associated access to reperfusion therapy: preliminary analysis of state linkage study07:59 minView Session
S4-2A. BonkhoffScientific Session #4Enhanced efficacy of acute intra-arterial recanalization therapies in female stroke patients09:37 minView Session
S4-3E. CamerucciScientific Session #4Sex differences in deep brain stimulation implants, management and levodopa adjustments in two population-based parkinsonism cohorts in minnesota06:26 minView Session
S4-4E. CamerucciScientific Session #4Incidence and Prevalence of Motor Fluctuations and Deep Brain Stimulation in Parkinson’s disease: A Comparison Between Two Population-based Cohorts in South East Minnesota07:19 minView Session
S4-5A. StangScientific Session #4Timeline, Incidence, Frequency and Survival of REM Sleep Behavior Disorder in Overt Alpha-Synucleinopathies06:36 minView Session
S4-6E. CamerucciScientific Session #4Early-onset parkinsonism and early-onset parkinson’s disease: a population-based study (2010-2015)05:10 minView Session
S5-1L. HarveyScientific Session #5: Neurological care and rehabilitation (2) Spinal cord injury rehabilitation education on a global scale (keynote lecture)14:37 minView Session
S5-2D. Gandhi Scientific Session #5: Neurological care and rehabilitation (2) Spinal cord injury rehabilitation education on a global scale (keynote lecture)16:21 minView Session
S5-3J. Marshall Scientific Session #5: Neurological care and rehabilitation (2) Virtual reality in aphasia rehabilitation: Applications of EVA Park09:06 minView Session
S5-4C. RiberholtScientific Session #5: Neurological care and rehabilitation (2) Early rehabilitation approaches in severe acquired brain injury10:14 minView Session
S6-1Y. CaoScientific Session #6Diet quality over middle adulthood and late-life subjective cognitive function among u.s. women07:18 minView Session
S6-2R. S. RagavanScientific Session #6Effect of varying look-back periods on estimating the trends in the incidence of stroke over time, using linked hospitalisation data07:05 minView Session
S6-3X. TianScientific Session #6Associations of hematological and biochemical markers with intracranial atherosclerosis: a systematic review and meta-analysis of observational studies08:41 minView Session
S6-4J. AkedScientific Session #6Survival, Functional Status and Recurrence Three Years After First-Ever Stroke in Southern Sweden09:40 minView Session
S6-5K. DokovaScientific Session #6Population-based stroke registry in varna, Bulgaria: feasibility and pilot data08:23 minView Session
S6-6A. AvanScientific Session #6Stroke and dementia, leading causes of neurological disability and death, potential for prevention05:50 minView Session
S6-7E. PupilloScientific Session #6Early onset and increased risk of als in italian professional soccer teams 07:44 minView Session
S7-1S. ChopraScientific Session #7Neuropsychological Rehabilitation after Traumatic Brain Injury in Low-Resource Settings – A Single Blind Randomized Study12:50 minView Session
S7-2R. M. JoseScientific Session #7Recurrent stroke in patients with atrial fibrillation: frequency and heterogeneity.05:56 minView Session
S7-3D. PanovScientific Session #7Job stress and risk of stroke in population 25-64 years in Russia/Siberia: gender issues. MONICA-psychosocial epidemiological study06:42 minView Session
S7-4A. GbessemehlanScientific Session #7Association between depression, anxiety and dementia among older people in Central Africa: EPIDEMCA population-based study.06:48 minView Session
S7-5S. SardesaiScientific Session #7Do dynamometric grip and pinch strengths correlate with upper limb capacity measured using action research arm test in stroke survivors?04:25 minView Session
S7-6A. K. MalahaScientific Session #7Costs of dementia in low and middle income countries: a systematic review06:09 minView Session
S8-1A. WiśniewskiScientific Session #8Validation of the National Institutes of Health Stroke Scale emphasizes its moderate psychometric properties09:55 minView Session
S8-2S. A. MioramalalaScientific Session #8Availability and cost of antiepileptic and psychotropic drugs after community-based interventions in Madagascar07:09 minView Session
S8-3L. ChenScientific Session #8Trends in clinical features and risk factors of amyotrophic lateral sclerosis: A 14-year cohort study in China07:06 minView Session
S8-4X. ChenScientific Session #8Plasma Folate Levels in Relation to Cognitive Function: A community-based cohort of older adults in China06:31 minView Session
S8-5M. VergonjeanneScientific Session #8Instruments for investigation of epilepsy in low- and middle- income countries: a systematic review06:22 minView Session
S8-6S.C.O. MartinsScientific Session #8Adressing Lifestyle Modefication and Primary Prevention in a Continental Country08:41 minView Session
S8-7A. TowfighiScientific Session #8Adressing Lifestyle for Stroke Prevention06:57 minView Session
EV. Feigin Closing remarks, Best Abstract AwardClosing remarks, Best Abstract Award03:21 minView Session
Eposter Library
Eposter N.Poster TitelMain AuthorCo-AuthorsSee the Poster
P1Feasibility of Dementia Assessments in the New Zealand (NZ) Indian CommunityRita KrishnamurthiAdrian Martinez-Ruiz, Susan Yates, Ekta Singh Dahiya, Sanjalin Naiker, Reshmi Bala, Sarah Cullum,click-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P2A QUALITATIVE STUDY OF FACTORS AFFECTING TIME TO TREATMENT OF ANEURYSMAL SUBARACHNOID HAEMORRHAGE – THE REDDISH STUDYThuy Phuong NguyenC. Stirling, G. Kitsos, L. Nichols, R. Chandra, S. Rehman, K. Smith, I. Mosley, L. Lai, H. Asadi, J. Froelich, N. Thani, A. Thrift, S. Gallclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P3Comorbidities in patients with epilepsy: frequency, mechanisms and effects on long-term outcomeGiorgia GiussaniElisa Bianchi MSc1*, Simone Beretta MD PhD2*, Davide Carone MD2*, Jacopo C DiFrancesco MD PhD2*, Andrea Stabile MD2, Clara Zanchi MD2, Marta Pirovano MD2, Claudia Trentini MD2, Giada Padovano MD2, Matteo Colombo MD2, Diletta Cereda MD2, Lorenzo Tinti MD2, Sofia Scanziani MD2, Sara Gasparini MD3, Graziella Bogliun MD2, Carlo Ferrarese MD PhD2, Ettore Beghi MD1*; for the PRO-LONG Study Group (#).click-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P4Stroke Mortality Trend in Uruguay: A 60 years National StudyStephanie PinoPino S, Rada D, Hackembruch H, Vázquez C, Ketzoina C, Gaye Saavedra A.click-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P5Acute Triage of Pediatric Stroke in Eastern DenmarkJulie BindslevKlaus Hansen, Christina Hoei-Hansen, Thomas Truelsenclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P6Cerebral infarction in young adults. Analysis of 104 cases.Otto Jesus Hernandez FustesM.S. Kawasaki, C. Arteaga Rodriguezclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P7Stroke subtypes in cancer patients and contributing risk factors in the stroke underlying mechanism, a retrospective studylama almubarakFarah Aleisa, MD, FRCPC, Hanouf Samadani, RNclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P8Excess Mortality in Stroke Patients Aged 80+ Years Receiving Acute Endovascular Recanalization Therapy, Eastern Denmark 2017-2019Nicolaj Grønbæk LaugesenNG. Laugesen, K. Hansen, T. Stavngaard, J. Højgaard, T. Truelsenclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P9Electrode Optimization for Home-Based Health Monitoring EEG AcquisitionTheeban ShivarajaWan Asyraf Wan Zaid, Noorfazila Kamal, Kalaivani Chellappanclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P10Migraine: A Cross-sectional Study among Physicians and Medical Students Regarding Prevalence, Awareness and Knowledge of Diagnosis and ManagementHassan ChoudryF. Ata, M. Suheb, N. Alamclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P11A CLUSTER-RANDOMISED CONTROLLED TRIAL EVALUATING THE EFFECTIVENESS OF STROKE RISKOMETER IN IMPROVING STROKE RISK AWARENESS IN ADULTS: A PRELIMINARY STUDYMohamad Zarudin Mat SaidZarudin MS, Kamarul Imran Musa, T.Alina T.Ismail, Anees AH, Ramesh Sahathevan, Zariah AA, Valery Feiginclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P12Validation of the Lebanese Arabic version of the BACS scale (the Brief Assessment of Cognition in Schizophrenia) among schizophrenic inpatientsChadia HaddadChadia Haddad, P. Salameh, S. Hallit, S. Obeid, G. Haddad, JP. Clément, B. Calvetclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P13Pontine Infarct with uncrossed Hemiparesis . A case reportAhmed ZAMIRDr Naveed Alamclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P14STROKE INCIDENCE IN SARS-COVID EPIDEMICS: THE EXPERIENCE OF ODESSAYurii VorokhtaMuratova T., Khramtsov D., Stoyanov A., Zbrozhek S., Voronina R., Khubetova I., Vikarenko M., Kozlova G., Dobush I., Andryuschenko E.click-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P15Epidemiology of Parkinson disease in Odessa (2017-2019)Yurii VorokhtaI. Khubetovaclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P16Evaluating the potential of mobile phone-based applications in improving stroke awareness among the Auckland Populationnavneet kaurclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P17Population-based validation of prehospital stroke scales for the detection of large vessel occlusion : Dijon Stroke RegistryGauthier DuloquinG. Duloquin, M. Graber, L. Garnier, V. Crespy, M. Giroud, Y. Bejotclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P19INCIDENCE AND CSF BIOMARKERS PATTERN IN FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) IN THE SALENTO AREA PUGLIAChiara ZeccaChiara Zecca, Maria Teresa Dell’Abate, Miriam Accogli, Rosa Capozzo, Maria Rosaria Barulli, Maria Elisa Frisullo, Giancarlo Logroscinoclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P20ASSOCIATION OF ANKLE-BRACHIAL INDEX WITH ISCHEMIC STROKE OUTCOME IN DIABETIC PATIENTS: A CASE-CONTROL STUDYFakhrur RazyFakhrurrazy, S. Manurung, A. Yuwono, H. Khatimahclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P21Synergies TO Prevent stroke – STOPstroke – an interdisciplinary research program on stroke preventionSeana GallAmanda Thrift, Judith Katzenellenbogen, Mark Nelson, Timothy Kleinig, Valery Feigin, Dominique Cadilhac, Lee Nedkoff, Joosup Kim, Monique Kilkennyclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P23Incidence and Prevalence of Stroke and its Risk Factors in the Philippines: A Systematic ReviewMaria Epifania CollantesZuniga YH, Uezono DRclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P24LOW VERSUS STANDARD DOSE OF INTRAVENOUS THROMBOLYSIS WITH ALTEPLASE IN ISCHEMIC STROKE PATIENTS OLDER THAN 80 YEARS OLD: AN OBSERVATIONAL STUDYLaura BaptisteS. Olindon, I. Sibon, Y. Béjotclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P25Paradoxical effect of smoking on motor progression and dopaminergic putaminal denervation in Parkinson’s disease.Daniele UrsoB. Tafuri, S. Nigro, G. Logroscinoclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P26Reduction in Acute Stroke Admissions During the COVID-19 Pandemic – Data from the Israeli National Stroke RegistryInbar ZuckerA. Ram, Y. Hershkovitz, D. Tanne, N. M. Bornstein, R. R. Leker, A. Horev, H. Hallevi, S. Peretz, D. Orion, I. Zuckerclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P27Synergies TO Prevent stroke – STOPstroke – an interdisciplinary research program on stroke preventionSeana GallAmanda Thrift, Judith Katzenellenbogen, Mark Nelson, Timothy Kleinig, Valery Feigin, Dominique Cadilhac, Lee Nedkoff, Joosup Kim, Monique Kilkennyclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
P28Application of motor learning principles in upper limb task-oriented training in stroke clinical trials – A scoping reviewSubramanian DurairajSanjukta Sardesai, Dr. Mindy F. Levin, Dr. John M. Solomonclick-here-button-hand-pointer-clicking-web-isolated-website-buy-register-bar-icon-finger-cursor-–-vector-stock-1371740601.png
Programme Day 2

[pdfjs-viewer url=”https://access.ianeneurology.org/download/day2.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]

Programme Day 1

[pdfjs-viewer url=”https://access.ianeneurology.org/download/day1.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]

Programme Day 3

[pdfjs-viewer url=”https%3A%2F%2Faccess.ianeneurology.org%2Fwp-content%2Fuploads%2F2021%2F01%2Ftelemed_Terms-of-Use_V1.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]

UMSA

Concept

Mobility has become one of the key issues in society today. Environmental problems and pandemic effects lead to changes in transportation, the quality of life in urban communities, and the development of urban clusters. At the same time, the ageing challenge triggers a profound impact on the social fabric of cities.

By 2030 all major urban centres in the OECD will see a sharp increase in the number of elderly – the share of aged 60 and above will grow from 30% to 39%. For the first time in history, the elderly will be the largest age group by 2045.

The global ageing of urban populations calls for more age-friendly approaches to be implemented. Cities will need to adapt and develop a number of short and longer-term strategies, integrating assistive technologies, to ensure they respond adequately to both the challenges and opportunities that an ageing population present.

All these challenges affect government and community engagement, and additionally the huge universe of R&D, innovation, business and corporate solutions linked to it.

 

UMSA Library
Number 1TitleAction
1What us UMSA about ?

Click to open

2Blog UMSA

Click to open

Contact our speakers
Library2demo
Number 1TitleAction
1What us UMSA about ?

Click to open

2Blog UMSA

Click to open

PAFSSH

European Menopause and Andropause Socety
Rue du Rhone, 118
CH-1204 Geneva
Phone: +41 22 510 1278
Email: info@emas-online.org

Library
Sr.noTitleAction
1Company Video

Click to open

2Pdf

Click to open

Contact
Exhibitor sample
[evp_embed_video url="https://vimeo.com/272444763" autoplay="true"]
1:1 meeting scheduling

Channel 1
VideoSlido

https://access.ianeneurology.org/wp-content/uploads/2020/08/Copy-of-Copy-of-Copy-of-pan-arb-2.png

https://streaming.salesbridges.com:5443/LiveApp/streams/669185674250831530552500.m3u8

Rate

Please give a rate


Comments to author

    Your Name (required)


    Your Email (required)




    Your subject


    Your comments to author


    Rating

    Please give a rate



    Exhibitor sample

    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

    Dr. Begoña Bermejo

     

    Physician and medical doctor from the University of Cadiz. Medical oncologist at the Clinical University Hospital of Valencia and Biomedical Research institute INCLIVA
    Associate Professor of Medicine School at University of Valencia

    She develops her assistance and research work in the breast pathology unit. She has an extensive experience in clinical trials and research projects in the area of breast cancer.Member of the breast cancer research group at the Carlos III institute.Member of the board of GEICAM (Spanish Breast Cancer Research Group)

     

    Dr. Enrique Santas Olmeda

     

    Dr. Enrique Santas, MD, PhD,  is a cardiologist at the Hospital Clínico Universitario in Valencia (Spain). He is an active clinician and an emergent researcher, with a focus on heart failure and cardiac imaging. Currently, he is the director of the cardio-oncology program at his institution, dedicated to the cardiovascular health of patients undergoing cancer treatment as well as cancer survivors.